The Cerebral Proteopathies
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 21 (1-2) , 083-096
- https://doi.org/10.1385/mn:21:1-2:083
Abstract
The abnormal assembly and deposition of specific proteins in the brain is the probable cause of most neurodegenerative disease afflicting the elderly. These “cerebral proteopathies” include Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), prion diseases, and a variety of other disorders. Evidence is accumulating that the anomalous aggregation of the proteins, and not a loss of protein function, is central to the pathogenesis of these diseases. Thus, therapeutic strategies that reduce the production, accumulation, or polymerization of pathogenic proteins might be applicable to a wide range of some of the most devastating diseases of old age.Keywords
This publication has 78 references indexed in Scilit:
- Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerizationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Aggregates in neurodegenerative disease: crowds and power?Trends in Neurosciences, 1999
- Mutations in RNA: a first example of molecular misreading in Alzheimer's diseaseTrends in Neurosciences, 1998
- Common core structure of amyloid fibrils by synchrotron X-ray diffraction 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Conformational diseaseThe Lancet, 1997
- Anti-Amyloid DrugsDrugs & Aging, 1996
- The Biophysics of Sickle Cell Hydroxyurea TherapyScience, 1995
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980